Denali Therapeutics Inc. (NAS: DNLI) Stock Analysis & Fundamentals | ScreenerHero

Create free account

DNLIDenali Therapeutics Inc.

NAS · US · Healthcare · Biotechnology · denalitherapeutics.com

23.29USD+2.46%Mkt Cap: 3.70B $P/E: —1d ago

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor p…

Industry Peers

Biotechnology

Vertex Pharmaceuticals Incorporated

$123.26BUSDP/E 28.8

Regeneron Pharmaceuticals, Inc.

$70.94BUSDP/E 16.5

$51.14BUSDP/E 38.1

$49.51BUSDP/E 29.8

Revolution Medicines, Inc.

Alnylam Pharmaceuticals, Inc.

$35.71BUSDP/E 67.0

Royalty Pharma plc

$33.50BUSDP/E 30.6

Insmed Incorporated

Incyte Corporation

$23.42BUSDP/E 16.6

$16.71BUSDP/E 21.6

BridgeBio Pharma, Inc.

$14.06BUSDP/E 18.5

Madrigal Pharmaceuticals, Inc.

ABIVAX Société Anonyme

Axsome Therapeutics, Inc.

BioMarin Pharmaceutical Inc.

$11.52BUSDP/E 42.9

Bio-Techne Corporation

$11.24BUSDP/E 103.0

Cytokinetics, Incorporated

Summit Therapeutics Inc.

Financière de Tubize SA

$9.97BUSDP/E 98.1

Arrowhead Pharmaceuticals, Inc.

Krystal Biotech, Inc.

$10.46BUSDP/E 47.4

Apogee Therapeutics, Inc.

Corcept Therapeutics Incorporated

$9.72BUSDP/E 258.6

Kymera Therapeutics, Inc.

Halozyme Therapeutics, Inc.

$9.23BUSDP/E 27.3

Protagonist Therapeutics, Inc.

Ionis Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

Praxis Precision Medicines, Inc.

Spyre Therapeutics, Inc.

TG Therapeutics, Inc.

$8.40BUSDP/E 19.2

Immunovant, Inc.

ImmunityBio, Inc.

Rhythm Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.

Cogent Biosciences, Inc.

Bachem Holding AG

$6.09BUSDP/E 35.9

PTC Therapeutics, Inc.

CG Oncology, Inc.

Scholar Rock Holding Corporation

Ligand Pharmaceuticals Incorporated

$6.08BUSDP/E 39.6

Belite Bio, Inc

Definium Therapeutics, Inc.

Dianthus Therapeutics, Inc.

Oruka Therapeutics, Inc.

Travere Therapeutics, Inc.

Caris Life Sciences, Inc.

Veradermics, Incorporated

Tango Therapeutics, Inc.

ACADIA Pharmaceuticals Inc.

$4.38BUSDP/E 11.6

Relay Therapeutics, Inc.

Legend Biotech Corporation

Viking Therapeutics, Inc.

Edgewise Therapeutics, Inc.

Dyne Therapeutics, Inc.

Camurus AB (publ)

$3.58BUSDP/E 55.6

Catalyst Pharmaceuticals, Inc.

$3.85BUSDP/E 18.2

Enliven Therapeutics, Inc.

Parabilis Medicines, Inc.

Arcutis Biotherapeutics, Inc.

Galera Therapeutics Inc

$3.47BUSDP/E 0.1

IDEAYA Biosciences, Inc.

Structure Therapeutics Inc.

Arcus Biosciences, Inc.

BB Biotech AG Ord

Zealand Pharma A/S

$2.97BUSDP/E 3.3

MBX Biosciences, Inc.

Disc Medicine, Inc.

Ultragenyx Pharmaceutical Inc.

Beam Therapeutics Inc.

BioArctic AB (publ)

$2.55BUSDP/E 126.1

Celldex Therapeutics, Inc.

Vera Therapeutics, Inc.

Trevi Therapeutics, Inc.

Maravai LifeSciences Holdings, Inc.

Kodiak Sciences Inc.

Tarsus Pharmaceuticals, Inc.

SELLAS Life Sciences Group, Inc.

Kailera Therapeutics, Inc.

Nurix Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Vericel Corporation

$2.38BUSDP/E 108.5

Agios Pharmaceuticals, Inc.

Nektar Therapeutics

Hemab Therapeutics Holdings, Inc.

Palvella Therapeutics, Inc.

Iovance Biotherapeutics, Inc.

Sionna Therapeutics, Inc.

Bavarian Nordic A/S

$2.03BUSDP/E 12.2

Monte Rosa Therapeutics, Inc.

Rapport Therapeutics, Inc.

Syndax Pharmaceuticals, Inc.

Nuvation Bio Inc.

ADMA Biologics, Inc.

$2.02BUSDP/E 12.8

Viridian Therapeutics, Inc.

Ocular Therapeutix, Inc.

UroGen Pharma Ltd.

Harmony Biosciences Holdings, Inc.

$1.96BUSDP/E 13.6

LAKEFRONT BIOTHERAPEUTICS

$1.85BUSDP/E 3.5

Nanobiotix S.A.

Tyra Biosciences, Inc.

Zenas BioPharma, Inc.

Bicara Therapeutics Inc.

Sarepta Therapeutics, Inc.

$1.82BUSDP/E 49.2

Stoke Therapeutics, Inc.

Generate Biomedicines, Inc.

AnaptysBio, Inc.

MapLight Therapeutics, Inc.

Taysha Gene Therapies, Inc.

Fortrea Holdings Inc.

MoonLake Immunotherapeutics

$1.54BUSDP/E 30.0

$1.60BUSDP/E 3.5

Vir Biotechnology, Inc.

Intellia Therapeutics, Inc.

Recursion Pharmaceuticals, Inc.

Maze Therapeutics, Inc.

ArriVent BioPharma, Inc.

Pharma Mar, S.A.

$1.42BUSDP/E 16.4

Absci Corporation

Aktis Oncology, Inc.

Inhibrx Biosciences, Inc.

First Tracks Biotherapeutics, Inc.

Jade Biosciences, Inc.

Avalyn Pharma Inc.

Corvus Pharmaceuticals, Inc.

MannKind Corporation

MeiraGTx Holdings plc

Capricor Therapeutics, Inc.

Seaport Therapeutics, Inc.

Philogen S.p.A.

$1.06BUSDP/E 4.2

ORIC Pharmaceuticals, Inc.

Cullinan Therapeutics, Inc.

Alto Neuroscience, Inc.

Lexicon Pharmaceuticals, Inc.

Avalo Therapeutics, Inc.

Olema Pharmaceuticals, Inc.

Forte Biosciences, Inc.

Janux Therapeutics, Inc.

Vor Biopharma Inc.

Kura Oncology, Inc.

Pharming Group N.V.

$879.74MUSDP/E 57.3

Geron Corporation

Arbutus Biopharma Corporation

$900.77MUSDP/E 5.5

LB Pharmaceuticals Inc

Oxford Biomedica plc

DBV Technologies S.A.

Sana Biotechnology, Inc.

Phathom Pharmaceuticals, Inc.

$817.88MUSDP/E 3.3

Replimune Group, Inc.

Solid Biosciences Inc.

Odyssey Therapeutics, Inc.

Basilea Pharmaceutica AG

$731.70MUSDP/E 16.5

Aclaris Therapeutics, Inc.

CytomX Therapeutics, Inc.

Design Therapeutics, Inc.

Zevra Therapeutics, Inc.

$754.90MUSDP/E 6.4

Rigel Pharmaceuticals, Inc.

$750.07MUSDP/E 2.1

Candel Therapeutics, Inc.

Monopar Therapeutics Inc.

Immix Biopharma, Inc.

Aura Biosciences, Inc.

Shattuck Labs, Inc.

XOMA Royalty Corporation

$710.16MUSDP/E 25.6

Omeros Corporation

$701.32MUSDP/E 8.5

ARS Pharmaceuticals, Inc.

BridgeBio Oncology Therapeutics, Inc.

Gyre Therapeutics, Inc.

Faeth Therapeutics, Inc.

SpyGlass Pharma, Inc.

$660.56MUSDP/E 3.9

MiMedx Group, Inc.

$640.47MUSDP/E 21.5

Allogene Therapeutics, Inc.

Tectonic Therapeutic, Inc.

Nuvectis Pharma, Inc.

4D Molecular Therapeutics, Inc.

Prime Medicine, Inc.

Altimmune, Inc.

Relmada Therapeutics, Inc.

Contineum Therapeutics, Inc.

Assembly Biosciences, Inc.

$531.30MUSDP/E 335.1

Eikon Therapeutics, Inc.

Crescent Biopharma, Inc.

Ginkgo Bioworks Holdings, Inc.

ProKidney Corp.

Sagimet Biosciences Inc.

Artiva Biotherapeutics, Inc.

Cabaletta Bio, Inc.

Editas Medicine, Inc.

Ovid Therapeutics Inc.

Kyverna Therapeutics, Inc.

Benitec Biopharma Inc.

Puma Biotechnology, Inc.

$434.17MUSDP/E 17.8

Eupraxia Pharmaceuticals Inc.

Tenax Therapeutics, Inc.

C4 Therapeutics, Inc.

Century Therapeutics, Inc.

Enanta Pharmaceuticals, Inc.

Abeona Therapeutics Inc.

$398.97MUSDP/E 7.4

DiaMedica Therapeutics Inc.

Sutro Biopharma, Inc.

Atea Pharmaceuticals, Inc.

Larimar Therapeutics, Inc.

Upstream Bio, Inc.

Avacta Group Plc

Rocket Pharmaceuticals, Inc.

Lexeo Therapeutics, Inc.

Fennec Pharmaceuticals Inc.

Zentalis Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc.

$345.91MUSDP/E 5.4

Palisade Bio, Inc.

$342.35MUSDP/E 16.4

Indaptus Therapeutics, Inc.

Hansa Biopharma AB (publ)

Prelude Therapeutics Incorporated

Vicore Pharma Holding AB (publ)

Inhibikase Therapeutics, Inc.

Vanda Pharmaceuticals Inc.

Fate Therapeutics, Inc.

Eledon Pharmaceuticals, Inc.

Lyell Immunopharma, Inc.

Foghorn Therapeutics Inc.

Egetis Therapeutics AB (publ)

Immuneering Corporation

Neumora Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.

MacroGenics, Inc.

Santhera Pharmaceuticals Holding AG

ALX Oncology Holdings Inc.

Galectin Therapeutics Inc.

Oryzon Genomics S.A.

Turn Therapeutics Inc.

SAB Biotherapeutics, Inc.

Opus Genetics, Inc.

Entrada Therapeutics, Inc.

Conexeu Sciences Inc.

Niagen Bioscience, Inc.

$261.23MUSDP/E 15.6

Fulcrum Therapeutics, Inc.

Cartesian Therapeutics, Inc.

Greenwich LifeSciences, Inc.

Protara Therapeutics, Inc.

Anavex Life Sciences Corp.

Nautilus Biotechnology, Inc.

Orchestra BioMed Holdings, Inc.

Circio Holding ASA

Coherus Oncology, Inc.

Karyopharm Therapeutics Inc.

Keros Therapeutics, Inc.

$208.63MUSDP/E 2.4

Atrium Therapeutics, Inc.

Atrys Health, S.A.

Precision BioSciences, Inc.

Minerva Neurosciences, Inc.

Tonix Pharmaceuticals Holding Corp.

Onward Medical N.V.

CAMP4 THERAPEUTICS CORPORATION

Whitehawk Therapeutics, Inc.

Voyager Therapeutics, Inc.

Saniona AB (publ)

$172.17MUSDP/E 7.9

NRx Pharmaceuticals, Inc.

Flerie AB (publ)

Canton Strategic Holdings, Inc.

Tenaya Therapeutics, Inc.

Korro Bio, Inc.

Arcturus Therapeutics Holdings Inc.

OnKure Therapeutics, Inc.

AN2 Therapeutics, Inc.

Outlook Therapeutics, Inc.

Corbus Pharmaceuticals Holdings, Inc.

Armata Pharmaceuticals, Inc.

Oramed Pharmaceuticals Inc.

$164.93MUSDP/E 1.6

Equillium, Inc.

Caribou Biosciences, Inc.

Acumen Pharmaceuticals, Inc.

LENZ Therapeutics, Inc.

Innate Pharma S.A.

Thor Medical ASA

Scancell Holdings plc

BioInvent International AB (publ)

Pyxis Oncology, Inc.

Hyloris Pharmaceuticals SA

Milestone Pharmaceuticals Inc.

Unicycive Therapeutics, Inc.

Molecular Partners AG

TuHURA Biosciences, Inc.

Genovis AB (publ.)

$126.38MUSDP/E 54.1

Heidelberg Pharma AG

Cue Biopharma, Inc.

vTv Therapeutics Inc.

$128.74MUSDP/E 3.3

Genelux Corporation

Fractyl Health, Inc.

Captor Therapeutics Spolka Akcyjna

Aardvark Therapeutics, Inc.

Spruce Biosciences, Inc.

Anixa Biosciences, Inc.

SynAct Pharma AB

Faron Pharmaceuticals Oy

Vivani Medical, Inc.

Fortress Biotech, Inc.

$111.62MUSDP/E 1.0

Polaryx Therapeutics, Inc.

Medivir AB (publ)

Coya Therapeutics, Inc.

Kalaris Therapeutics, Inc.

Black Diamond Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

ImmuCell Corporation

ArcticZymes Technologies ASA

$89.99MUSDP/E 72.5

Verrica Pharmaceuticals Inc.

Rani Therapeutics Holdings, Inc.

Pelthos Therapeutics Inc.

Nykode Therapeutics AS

$88.03MUSDP/E 11.0

Biomea Fusion, Inc.

Inovio Pharmaceuticals, Inc.

Infant Bacterial Therapeutics AB (publ)

Spero Therapeutics, Inc.

$91.48MUSDP/E 5.9

ABIONYX Pharma SA

Ryvu Therapeutics S.A.

NeOnc Technologies Holdings, Inc.

Heron Therapeutics, Inc.

$82.96MUSDP/E 76.3

OSE Immunotherapeutics SA

Rallybio Corporation

Cognition Therapeutics, Inc.

Champions Oncology, Inc.

Gossamer Bio, Inc.

AlzeCure Pharma AB (publ)

Elicio Therapeutics, Inc.

Nanoform Finland Oyj

MAIA Biotechnology, Inc.

Telomir Pharmaceuticals, Inc.

Adicet Bio, Inc.

Atara Biotherapeutics, Inc.

Helix BioPharma Corp.

Acrivon Therapeutics, Inc.

Xspray Pharma AB (publ)

Annovis Bio, Inc.

Rein Therapeutics Inc.

Gain Therapeutics, Inc.

PMV Pharmaceuticals, Inc.

Pliant Therapeutics, Inc.

OS Therapies Incorporated

MediciNova, Inc.

Oncopeptides AB (publ)

Pentixapharm Holding AG N

THX Pharma Société Anonyme

Hemogenyx Pharmaceuticals Plc

ImageneBio, Inc.

Cardiff Oncology, Inc.

TScan Therapeutics, Inc.

Xilio Therapeutics, Inc.

Boundless Bio, Inc.

Context Therapeutics Inc.

MiNK Therapeutics, Inc.

BeyondSpring Inc.

Seres Therapeutics, Inc.

Herantis Pharma Oyj

Filana Therapeutics, Inc.

INmune Bio Inc.

Instil Bio, Inc.

aTyr Pharma, Inc.

Impact BioMedical Inc.

Corline Biomedical AB

Cantargia AB (publ)

$43.71MUSDP/E 2.9

Eastwood Bio-Medical Canada Inc.

Metagenomi Therapeutics, Inc.

Dogwood Therapeutics, Inc.

$46.41MUSDP/E 1.2

Dyadic International, Inc.

Synthaverse S.A.

Hyperion DeFi, Inc.

Intervacc AB (publ)

Eloxx Pharmaceuticals, Inc.

PDS Biotechnology Corporation

Apollomics, Inc.

Sprint Bioscience AB (publ)

$36.94MUSDP/E 3.9

Arch Biopartners Inc.

NanoViricides, Inc.

Vivoryon Therapeutics N.V.

Mendus AB (publ)

Sareum Holdings plc

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

$41.13MUSDP/E 5.7

Lantern Pharma Inc.

genOway Société anonyme

$34.47MUSDP/E 25.7

Estrella Immunopharma, Inc.

Aligos Therapeutics, Inc.

Actuate Therapeutics, Inc. Common stock

Lite Strategy, Inc.

Lisata Therapeutics, Inc.

Tvardi Therapeutics, Inc.

SkinBioTherapeutics plc

Daré Bioscience, Inc.

Kyntra Bio, Inc.

Microbix Biosystems Inc.

Actinium Pharmaceuticals, Inc.

IGC Pharma, Inc.

GridAI Technologies Corp.

Plus Therapeutics, Inc.

$25.75MUSDP/E 0.2

VYNE Therapeutics Inc.

Atossa Therapeutics, Inc.

Jasper Therapeutics, Inc.

Isofol Medical AB (publ)

SoftOx Solutions AS

Medicenna Therapeutics Corp.

Xbrane Biopharma AB (publ)

Celularity Inc.

Resverlogix Corp.

GenSight Biologics S.A.

Marker Therapeutics, Inc.

ZIVO Bioscience, Inc.

CEL-SCI Corporation

Cellectar Biosciences, Inc.

Longeveron Inc.

Allarity Therapeutics, Inc.

Quince Therapeutics, Inc.

Neuphoria Therapeutics Inc.

Werewolf Therapeutics, Inc.

Diamyd Medical AB (publ)

Tevogen Bio Holdings Inc.

Xintela AB (publ)

Simris Group AB (PUBL)

OSR Health, Inc.

$16.40MUSDP/E 15.6

Palatin Technologies, Inc.

$16.17MUSDP/E 82.6

SeaStar Medical Holding Corporation

Cyclerion Therapeutics, Inc.

Passage Bio, Inc.

Tempest Therapeutics, Inc.

Nanologica AB (publ)

$13.93MUSDP/E 1.6

Vyome Holdings, Inc.

Pasithea Therapeutics Corp.

Moleculin Biotech, Inc.

Fusion Antibodies plc

HOOKIPA Pharma Inc.

Active Biotech AB (publ)

Alzinova AB (publ)

Devonian Health Group Inc.

Citius Pharmaceuticals, Inc.

Senti Biosciences Holdings, Inc.

Celyad Oncology SA

$12.65MUSDP/E 13.0

Cocrystal Pharma, Inc.

Intensity Therapeutics, Inc.

GT Biopharma, Inc.

Biovica International AB (publ)

Lunai Bioworks Inc.

NextCell Pharma AB

BioCardia, Inc.

Alligator Bioscience AB (publ)

Phio Pharmaceuticals Corp.

IRLAB Therapeutics AB (publ)

Kiora Pharmaceuticals, Inc.

CalciMedica, Inc.

Theriva Biologics, Inc.

OncoZenge AB (publ)

Traws Pharma, Inc.

Scandinavian ChemoTech AB

Brainstorm Cell Therapeutics Inc.

Annexin Pharmaceuticals AB (publ)

Hemostemix Inc.

Vistagen Therapeutics, Inc.

Spago Nanomedical AB (publ)

Aprea Therapeutics, Inc.

Marinomed Biotech AG

$8.26MUSDP/E 0.4

Plant Advanced Technologies SA

$8.25MUSDP/E 13.1

Bolt Biotherapeutics, Inc.

EXACT Therapeutics AS

Arctic Bioscience AS

Jupiter Neurosciences, Inc.

Aspire Biopharma Holdings, Inc.

TransCode Therapeutics, Inc.

NKGen Biotech, Inc.

AEON Biopharma, Inc.

Liminatus Pharma, Inc.

Addex Therapeutics Ltd

Ernexa Therapeutics Inc.

AcouSort AB (publ)

Reviva Pharmaceuticals Holdings, Inc.

CNS Pharmaceuticals, Inc.

Euroespes, S.A.

AIM ImmunoTech Inc.

Pure Biologics S.A.

Ascelia Pharma AB (publ)

Cadrenal Therapeutics, Inc.

Acurx Pharmaceuticals, Inc.

Kairos Pharma, Ltd.

OptiBiotix Health Plc

Processa Pharmaceuticals, Inc.

HCW Biologics Inc.

Jaguar Health, Inc.

Xenetic Biosciences, Inc.

Pulmatrix, Inc.

Adial Pharmaceuticals, Inc.

Aptevo Therapeutics Inc.

$5.91MUSDP/E 0.0

Curanex Pharmaceuticals Inc

Quantum Genomics Société Anonyme

Enveric Biosciences, Inc.

Dermata Therapeutics, Inc.

Soligenix, Inc.

Bio Green Med Solution, Inc.

$5.23MUSDP/E 0.2

Cardio Diagnostics Holdings, Inc.

GeoVax Labs, Inc.

Alaunos Therapeutics, Inc.

PMGC Holdings Inc.

Mustang Bio, Inc.

Fluicell AB (publ)

$4.34MUSDP/E 0.0

Revelation Biosciences, Inc.

Alzamend Neuro, Inc.

FibroBiologics, Inc.

Ensysce Biosciences, Inc.

Strategic Partners A/S

60 Degrees Pharmaceuticals, Inc.

Artelo Biosciences, Inc.

Kane Biotech Inc.

StageZero Life Sciences Ltd.

Guard Therapeutics International AB (publ)

Innovotech Inc.

Lakewood-Amedex Biotherapeutics, Inc.

Decoy Therapeutics Inc.

$2.98MUSDP/E 0.1

Onconetix, Inc.

$2.81MUSDP/E 0.0

$2.66MUSDP/E 0.0

Oragenics, Inc.

Quest PharmaTech Inc.

$2.46MUSDP/E 0.7

Calidi Biotherapeutics, Inc.

Matinas BioPharma Holdings, Inc.

Magle Chemoswed Holding AB (publ)

Clearside Biomedical, Inc.

Futura Medical plc

VivoSim Labs, Inc.

CDT Equity Inc.

$1.98MUSDP/E 0.0

BSF Enterprise Plc

Bio-Path Holdings, Inc.

Hepion Pharmaceuticals, Inc.

$1.62MUSDP/E 0.0

Appili Therapeutics Inc.

Evofem Biosciences, Inc.

ZyVersa Therapeutics, Inc.

Waverley Pharma Inc.

Lyra Therapeutics, Inc.

Avenue Therapeutics, Inc.

Sorrento Therapeutics, Inc.

CERo Therapeutics Holdings, Inc.

$496.2KUSDP/E 0.0

Protagenic Therapeutics, Inc.

Windtree Therapeutics, Inc.

$455.1KUSDP/E 0.0

$449.7KUSDP/E 0.9

Carisma Therapeutics, Inc.

$238.5KUSDP/E 0.0

Lipella Pharmaceuticals Inc.

Ocean Biomedical, Inc.

PaxMedica, Inc.

$88.4KUSDP/E 0.0

Vincerx Pharma, Inc.

Panbela Therapeutics, Inc.

Anebulo Pharmaceuticals, Inc.

Scopus BioPharma Inc.

Virpax Pharmaceuticals, Inc.

Vaxxinity, Inc.

Better Therapeutics, Inc.

Aridis Pharmaceuticals, Inc.

Kaleido Biosciences, Inc.

Comera Life Sciences Holdings, Inc.

eFFECTOR Therapeutics, Inc.

Syros Pharmaceuticals, Inc.

Evelo Biosciences, Inc.

NexImmune, Inc.

Idogen AB (publ)

Bio Green Med Solution, Inc.

Aspire Biopharma Holdings, Inc.

Biofrontera Inc.

bioAffinity Technologies, Inc.

Celularity Inc.

HeartSciences Inc.

Dermata Therapeutics, Inc.

AB Corporate Bond ETF

The Oncology Institute, Inc.

XOMA Royalty Corporation

Fortress Biotech, Inc.

CDT Equity Inc.

Cardio Diagnostics Holdings, Inc.

XOMA Royalty Corporation

Bitwise MARA Option Income Strategy ETF

60 Degrees Pharmaceuticals, Inc.

Indicators:|

Headline	Source	Time
This week
Slate Medicines Appoints Mark W. Hahn to Board of Directors By Daniella Parra Slate Medicines, a private biotech company developing new treatments for migraine and other headache disorders, has appointed Mark W. Hahn to its Board of Directors, they said. The company said Hahn brings more than 25 years of life sciences leadership experience, including serving as CFO of Verona Pharma, where he helped guide […] The post Slate Medicines Appoints Mark W. Hahn to Board of Directors appeared first on ExecEdge.	Exec Edge	1d
Will Recent Setbacks Impact Growth Prospects of DNLI Stock? Denali Therapeutics gains FDA approval for Avlayah, but pipeline setbacks and partner exits raise fresh questions as key clinical programs continue.	Zacks	Jul 15
Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?	Barrons.com	Jul 13
Older
Regenxbio Shares Rise on Plans to Resubmit Navsunli BLA for MPS II	Zacks	Jun 23
Denali to Sell Priority Review Voucher for $195M Cash Boost	Zacks	Jun 19
Pfizer CFO to step down; Denali sells a regulatory fast-pass	BioPharma Dive	Jun 18
Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease	Exec Edge	Jun 16
What Makes Denali Therapeutics (DNLI) One of the Best AI Driven Biotech Names	Insider Monkey	Jun 11
Biogen Ends BIIB122 Parkinsons Trial And Refocuses Neurodegeneration Pipeline	Simply Wall St.	Jun 2
Denali Therapeutics Inc. (DNLI): One of the Top Stock Picks of Jeff Bezos	Insider Monkey	Jun 1
Denali Therapeutics' Focus Shifts to Other Pipeline Assets After Phase 2b Study Failure, Morgan Stanley Says	MT Newswires	May 26
Stocks Settle Higher on Iran Peace Hopes and Tech Strength	Barchart	May 22
Biogen Faces Trial Setbacks And Probes That Reframe Neuro Pipeline Risks	Simply Wall St.	May 22
Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails	Zacks	May 22
Stocks Climb on US-Iran Peace Hopes and Strength in Chipmakers	Barchart	May 22
Stocks Supported by US-Iran Peace Deal Optimism	Barchart	May 22
Parkinson’s drug from Biogen, Denali comes up short	BioPharma Dive	May 22
BIIB, DNLI Stocks Edge Lower After Hours: Parkinson’s Drug Misses Key Goals In Trial	Stocktwits	May 21
Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval	Motley Fool	May 18
Denali Therapeutics Says AVLAYAH Launch Ahead of Expectations After Hunter Syndrome Approval	MarketBeat	May 16